Measurement of pediatric cancer patients' health-related quality of life (HRQL) in phase III randomized, controlled clinical trials is being recognized increasingly as an essential component in evaluating the comprehensive health outcomes of modern anti-neoplastic treatment protocols. Use of a brief
P1.32: Screening for and Promotion of Health-related Quality of Life in Children and Adolescents - the European Public Health Approach KIDSCREEN
β Scribed by Ulrike Ravens-Sieberer; Michael Erhart; Mick Power; Pascal Auquier; Bernhard Cloetta; Curt Hagquist; Jeanet Bruil; Wolfgang Duer; Luis Ramil
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 77 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0323-3847
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The purpose of this report is to provide a brief summary of discussions that took place at the International Workshop. This report is meant to complement the perspectives provided by the discussants (G. Guyatt, J. Landgraf and B. Pollock) in their reports and in the commentary provided by G.A. Monac
The approach of the National Cancer Institute of Canada Clinical Trials Group to measuring compliance, that is, completion rates, for health-related quality of life questionnaires is presented. Completion rates can be measured at the institutional, patient, questionnaire and item levels for baseline